NovaBay Pharmaceuticals, Inc. -NYSE-Amex:NBY
Developing Anti-Infective Compounds Effective Against Bacteria, Viruses and Fungi.
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market. We are currently focused primarily on commercializing prescription Avenova® for managing hygiene of the eyelids and lashes in the United States.
Avenova is the only eye care product formulated with a proprietary, stable and pure form of hypochlorous acid called Neutrox®.
By replicating the anti-microbial chemicals used by white blood cells to fight infection,
Neutrox has proven in laboratory testing to have broad antimicrobial properties.
Avenova with Neutrox removes debris from the skin on eyelids and lashes without burning or stinging.
We have developed additional commercial products containing Neutrox, including our NeutroPhase® Skin and Wound Cleanser for wound care and CelleRx® for the dermatology market.
We have partnerships for NeutroPhase in the U.S. as well as select overseas markets, most notably China.